Trials / Completed
CompletedNCT03631446
Drug Use-Results Survey on Picoprep® Combination Powder
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,298 (actual)
- Sponsor
- Ferring Pharmaceuticals · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this survey is to confirm safety and efficacy with patients who are administered the Picoprep® for cleansing of intestinal contents for preparation of colonoscopy and colorectal surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sodium Picosulfate, Magnesium Oxide and Citric Acid | Combination powder for oral solution |
Timeline
- Start date
- 2017-08-29
- Primary completion
- 2021-12-31
- Completion
- 2021-12-31
- First posted
- 2018-08-15
- Last updated
- 2022-01-18
Locations
1 site across 1 country: Japan
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03631446. Inclusion in this directory is not an endorsement.